Metraipolis › archive › dc_6e7e8967cb93
Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma — Europe PMC PMID:41440490
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41440490
- DOI
- 10.3390/antib14040101
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T06:51:39.382Z
- SHA-256 of the archived text
d6b4a66099fc39c787123f74eaac15cfeda97aa960fbc509cbd1b848002f308b- Stable URL of this page
https://metraipolis.com/documento/dc_6e7e8967cb93
How to cite
Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma — Europe PMC PMID:41440490 — Europe PMC (en), https://europepmc.org/article/MED/41440490 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e7e8967cb93 (Metraipolis archive dc_6e7e8967cb93, sha256 d6b4a66099fc39c787123f74eaac15cfeda97aa960fbc509cbd1b848002f308b)
BibTeX
@misc{dc6e7e8967cb93,
title = {Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma — Europe PMC PMID:41440490},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41440490},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e7e8967cb93; sha256 d6b4a66099fc39c787123f74eaac15cfeda97aa960fbc509cbd1b848002f308b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41440490. Agents can read the archived copy with the MCP tool read_document.